Applications of high-throughput methods to cancer metastases

Journal of Musculoskeletal Neuronal Interactions

Volumn 2, Issue 6, 2002, Pages 575-578

  Keller, E T ^a   Yao, Z ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Gene array; Genomics; Prostate cancer; Proteomics; Transcription factor

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; DNA MICROARRAY; DRUG TARGETING; METASTASIS; METHODOLOGY; PROGNOSIS; PROSTATE CANCER; PROTEOMICS; STATISTICAL ANALYSIS;

EID: 0036976238     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Li X, Gu W, Mohan S, Baylink DJ. DNA microarrays: their use and misuse. Microcirculation 2002; 9:13-22.
2. Gabig M, Wegrzyn G. An introduction to DNA chips: principles, technology, applications and analysis. Acta Biochim Pol 2001; 48:615-622.
3. Ho SM, Lau KM. DNA microarrays in prostate cancer. Curr Urol Rep 2002; 3:53-60.
4. Bilban M, Buehler LK, Head S, Desoye G, Quaranta V. Normalizing DNA microarray data. Curr Issues Mol Biol 2002; 4:57-64.
5. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM. Delineation of prognostic biomarkers in prostate cancer. Nature 2001; 412:822-826.
6. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR, Sellers WR. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002; 1:203-209.
7. Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, Klaren R, Grone EF, Wiesel M, Gudemann C, Kuster J, Schott W, Staehler G, Kretzler M, Hollstein M, Grone HJ. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am J Pathot 2002; 160:2169-2180.
8. Porkka K, Saramaki O, Tanner M, Visakorpi T. Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays. Lab Invest 2002; 82:629-637.
9. Mousses S, Bubendorf L, Wagner U, Hostetter G, Kononen J, Cornelison R, Goldberger N, Elkahloun AG, Willi N, Koivisto P, Ferhle W, Raffeld M, Sauter G, Kallioniemi OP. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res 2002; 62:1256-1260.
10. Walter G, Bussow K, Lueking A, Glokler J. High-throughput protein arrays: prospects for molecular diagnostics. Trends Mol Med 2002; 8:250-253.
11. Zhou H, Roy S, Schulman H, Natan MJ. Solution and chip arrays in protein profiling. Trends Biotechnol 2001; 19:S34-39.
12. Abbott A. A post-genomic challenge: learning to read patterns of protein synthesis. Nature 1999; 402:715-720.
13. de Wildt RM, Mundy CR, Gorick BD, Tomlinson IM. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol 2000; 18:989-994.
14. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359:572-577.
15. Rubin MA, Dunn R, Strawderman M, Pienta KJ. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002; 26:312-319.
16. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4:844-847.
17. Bubendorf L, Kolmer M, Kononen J, Koivisto P, Mousses S, Chen Y, Mahlamaki E, Schraml P, Moch H, Willi N, Elkahloun AG, Pretlow TG, Gasser TC, Mihatsch MJ, Sauter G, Kallioniemi OP. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 1999; 91:1758-1764.
18. Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001; 10:657-662.